CN Bio PhysioMimix Organ-on-a-Chip data supports Inipharm’s INI-822 for metabolic liver disease treatment now in clinical testing Post author: Post published:December 4, 2023 Post category:uncategorized CN Bio today announced its PhysioMimix® assay for Non-alcoholic steatohepatitis (NASH). You Might Also Like New ingestible sensor for non-intrusive sleep disorder monitoring developed by MIT and collaborators November 24, 2023 New report highlights urgent need to improve thalassemia awareness among Azerbaijan women November 17, 2023 Ovarian reserve unchanged by hydroxyurea in sickle cell disease, study reveals July 18, 2024
New ingestible sensor for non-intrusive sleep disorder monitoring developed by MIT and collaborators November 24, 2023
New report highlights urgent need to improve thalassemia awareness among Azerbaijan women November 17, 2023